Report Library
View More
Key Potential Drug Launches in 2026
September 17, 2025
Datamonitor Healthcare CV&Met: Isch...
September 15, 2025
Datamonitor Healthcare CV&Met: Veno...
September 15, 2025
Datamonitor Healthcare I&I: Systemi...
September 15, 2025
Datamonitor Healthcare CV&Met: Chem...
September 15, 2025
Datamonitor Healthcare Oncology: Gl...
September 15, 2025
Datamonitor Healthcare Other: Erect...
September 15, 2025
Datamonitor Healthcare Other: Hypog...
September 15, 2025
Datamonitor Healthcare CV&Met: Amyl...
September 15, 2025
Datamonitor Healthcare Oncology: Tu...
September 15, 2025
Datamonitor Healthcare Oncology: Sm...
September 15, 2025
Datamonitor Healthcare CNS: Neuropa...
September 15, 2025
Datamonitor Healthcare Oncology: Me...
September 15, 2025
Datamonitor Healthcare I&I: Glaucom...
September 15, 2025
Datamonitor Healthcare Oncology Dis...
September 12, 2025
Datamonitor Healthcare I&I Disease ...
September 12, 2025
Datamonitor Healthcare CV&Met Disea...
September 10, 2025
Dealmaking Quarterly Statistics, Q2...
September 4, 2025
Financing Quarterly Statistics, Q2 ...
September 4, 2025
Datamonitor Healthcare Oncology Dis...
September 3, 2025
Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 9/16/25 | SK Biopharmaceuticals (A326030) | Xcopri for Tonic-Clonic Seizures (Epilepsy) | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/11/25 | Alfasigma | Ocaliva for Primary Biliary Cholangitis (PBC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/11/25 | Merck & Co (MRK) | Capvaxive for Pneumococcal (Streptococcus pneumoniae) Vaccines (Antibacterial) | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/10/25 | Avidity Biosciences (RNA) | Del-zota for Duchenne Muscular Dystrophy (DMD) | Subscribers Only | Subscribers Only | Subscribers Only |
| 9/8/25 | Rapport Therapeutics (RAPP) | RAP-219 for Partial / Focal Seizures (Epilepsy) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 06/25/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 06/25/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 06/26/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 06/30/2025 | Subscribers Only | Subscribers Only | Trial Data - Updated Results |
| 09/08/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |